The ReAct network seeks to base all activities on the most firm, available scientific evidence and constantly strives to promote and support evidence generation. The development of a global surveillance system for antibiotic resistance, antibiotic use and the burden of resistance has become increasingly called for as the issue of antibiotic resistance has gained attention, and ReAct is actively involved in supporting this process at several levels.
Efforts to improve surveillance need to specifically address the needs of low- and middle income countries and in particular Sub-Saharan Africa, where data are still scanty, but alarming reports are beginning to come out.
A global system for surveillance is needed to develop appropriate local treatment guidelines, to detect new resistant pathogens and to better understand the dynamics of the spread of resistance genes. In addition, the systematic collection of surveillance data globally is also important to inform needs-driven R&D for novel antibiotics, diagnostics and associated health technologies.
ReAct works with various partners to support increased data generation in low- and middle income countries.
COSTS AND CONSEQUENCES OF ABR IN SEA HOSPITALS
In 2011 ReAct South East Asia (SEA) initiated and supported (with co-funding from WHO-WPRO), to develop a study protocol on the "Costs and Consequences of Antibiotic Resistance in Bacteraemic Patients in South East Asian Hospitals"
JOINT INDEPTH-ReAct WORKSHOP ON ANTIBIOTIC RESISTANCE
The meeting, in October 2009, was attended by 33 participants representing four continents; Asia, Africa, Europe and Oceania. The purpose of the workshop was to explore the possibility for the two networks to collaborate in the field of antibiotic resistance. This meeting was followed up by a joint workshop in Bangladesh in May 2010.